Regulatory Affairs

FDA FDA Approval Drug Approval FDA Approvals Drug Approval Process FDA Approval Process Drug Regulation FDA Regulations Drug Safety FDA Guidelines Food Regulations Clinical Research Medical Products Global Health Policies Marketing Authorization FDA Designations European Medicines Agency AIFA Accelerated Approval Drug Approvals FDA Actions Medical Cannabis US Food and Drug Administration Anvisa Vaccine Approval Medical Device Approval

Peptide Craze Grows as HHS Chief Backs Wider Access

A fast-rising wellness trend centers on lab-made protein fragments that span strict drug rules and looser supplement oversight.

Novo Nordisk Strikes Hims & Hers Deal for Ozempic and Wegovy, Drops Patent Suit

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

Sarepta Reports 3-Year EMBARK Data Showing Elevidys Slows Duchenne Progression

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

Dyne’s DMD Drug Hits Primary Endpoint in DELIVER REC, Shows Functional Gains

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly

EU Regulators Back Uplizna as First Treatment for IgG4‑Related Disease

CSL Secures VarmX Acquisition Option, Funding Phase 3 of Factor Xa Reversal Drug

FDA Approves First New Fibromyalgia Treatment in 15 Years

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

Leukemia-on-a-Chip Enables Rapid, Scalable CAR T-Cell Therapy Screening

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications